Home

CHRIS W BODINE

CIK 1194405 · Executive Vice President · last filed 2025-10-06

CHRIS W BODINE is an Executive Vice President who has filed 43 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for ONEW, was dated Apr 22, 2026. Across all open-market trades the lifetime net is −$18.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.4M across reported positions. 17 SEC filings were submitted jointly with Actavis plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.38M

Companies

5

Total Filings

43

Lifetime Open-Market Net

-$18.85M

Filer Profile

Reported Address
ONE CVS DR
WOONSOCKET, RI 02895
Related Filers
Actavis plc — 17 joint filings, latest 2020-05-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ONEW Director 33,928 $12.70 $430.9K $0 9 2025-10-06
Allergan plc (AGN) Delisted Director 0 — — $499.3K 11 2020-05-11
ACT Director 12,222 $49.27 $602.2K $0 2 2015-06-08
Actavis, Inc. (WPI) Delisted Director 15,352 — — $0 4 2012-05-14
CVS Executive Vice President 293,003 $96.74 $28.35M -$19.34M 9 2009-02-20

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-22 ONEW Notice (144) −26,036 -$287.8K EDGAR
2025-10-06 ONEW Grant (A) +7,892 $0 EDGAR
2024-10-03 ONEW Grant (A) +5,228 $0 EDGAR
2023-10-03 ONEW Grant (A) +4,880 $0 EDGAR
2023-02-27 ONEW Grant (A) +1,661 $0 EDGAR
2022-10-04 ONEW Grant (A) +2,491 $0 EDGAR
2022-02-24 ONEW Grant (A) +1,866 $0 EDGAR
2021-10-04 ONEW Grant (A) +2,487 $0 EDGAR
2020-10-05 ONEW Grant (A) +3,660 $0 EDGAR
2020-05-11 Allergan plc (AGN) Delisted Disp (D) −18,615 $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.